BFG
Bleakley Financial Group Portfolio holdings
AUM
$3.94B
This Quarter Return
-2.73%
1 Year Return
+21.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.84B
AUM Growth
+$2.84B
(-11%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-9.42%
Top 10 Holdings %
Top 10 Hldgs %
27.49%
Holding
971
New
45
Increased
241
Reduced
576
Closed
86
Top Buys
| 1 |
Novo Nordisk
NVO
|
$7.87M |
| 2 |
Tenet Healthcare
THC
|
$5.66M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$5.49M |
| 4 |
AAM Low Duration Preferred and Income Securities ETF
PFLD
|
$5.28M |
| 5 |
Freeport-McMoran
FCX
|
$3.29M |
Top Sells
| 1 |
Vanguard Large-Cap ETF
VV
|
$42.9M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$42.4M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
$27.1M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$16M |
| 5 |
Vanguard Total World Stock ETF
VT
|
$13M |
Sector Composition
| 1 | Technology | 11.99% |
| 2 | Healthcare | 11.28% |
| 3 | Financials | 5.33% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Opendoor
OPEN
$3.75B
| $53.6K | ﹤0.01% |
20,286
-2,099
| -9% | -$5.54K |
|
852
NextNav
NN
$2.34B
| $52.7K | ﹤0.01% |
10,261
-2,000
| -16% | -$10.3K |
|
853
Perimeter Solutions
PRM
$3.3B
| $51.8K | ﹤0.01% |
11,415
-2,034
| -15% | -$9.23K |
|
|
IAUX
854
i-80 Gold Corp
IAUX
$671M
| $49.2K | ﹤0.01% |
+32,180
| New | +$49.2K |
|
|
DHC
855
Diversified Healthcare Trust
DHC
$910M
| $46.4K | ﹤0.01% |
23,913
-822
| -3% | -$1.6K |
|
856
SCYNEXIS
SCYX
$35M
| $45.6K | ﹤0.01% |
20,000
| – | – |
|
857
Lloyds Banking Group
LYG
$63.6B
| $40.6K | ﹤0.01% |
19,053
-8,854
| -32% | -$18.9K |
|
858
GoPro
GPRO
$236M
| $39.8K | ﹤0.01% |
+12,684
| New | +$39.8K |
|
859
ADMA Biologics
ADMA
$4.1B
| $37.4K | ﹤0.01% |
10,458
-564
| -5% | -$2.02K |
|
860
Compass
COMP
$4.7B
| $33.6K | ﹤0.01% |
11,587
+915
| +9% | +$2.65K |
|
861
Aurora
AUR
$10.7B
| $33.4K | ﹤0.01% |
+14,198
| New | +$33.4K |
|
862
Tilray
TLRY
$1.37B
| $32.2K | ﹤0.01% |
+13,469
| New | +$32.2K |
|
863
TrueCar
TRUE
$187M
| $31.8K | ﹤0.01% |
15,374
-752
| -5% | -$1.56K |
|
|
CTEV
864
Claritev Corporation
CTEV
$1.14B
| $30.1K | ﹤0.01% |
17,912
-1,092
| -6% | -$1.84K |
|
865
Esperion Therapeutics
ESPR
$468M
| $29.9K | ﹤0.01% |
+30,502
| New | +$29.9K |
|
866
Seres Therapeutics
MCRB
$171M
| $26.9K | ﹤0.01% |
+11,294
| New | +$26.9K |
|
867
Gannett
GCI
$592M
| $26.1K | ﹤0.01% |
10,635
-328
| -3% | -$804 |
|
868
Fate Therapeutics
FATE
$119M
| $25.5K | ﹤0.01% |
+12,012
| New | +$25.5K |
|
869
Crexendo
CXDO
$194M
| $23.2K | ﹤0.01% |
11,000
| – | – |
|
870
Pyxis Oncology
PYXS
$82.5M
| $22.4K | ﹤0.01% |
+11,234
| New | +$22.4K |
|
871
Seer Inc
SEER
$115M
| $22.2K | ﹤0.01% |
+10,051
| New | +$22.2K |
|
872
Xeris Biopharma Holdings
XERS
$1.28B
| $20.5K | ﹤0.01% |
+11,048
| New | +$20.5K |
|
873
Ginkgo Bioworks
DNA
$652M
| $18.7K | ﹤0.01% |
10,321
-6,115
| -37% | -$11.1K |
|
874
SelectQuote
SLQT
$373M
| $12.8K | ﹤0.01% |
+10,970
| New | +$12.8K |
|
875
Clover Health Investments
CLOV
$1.38B
| $12K | ﹤0.01% |
11,074
-15
| -0.1% | -$16 |
|